CiNii Articles - aldosterone

1

Relationship Between Biological Variation in B-Type Natriuretic Peptide and Plasma Renin Concentration in Stable Outpatients With Dilated Cardiomyopathy

NISHIYAMA Keizo , TSUTAMOTO Takayoshi , KAWAHARA Chiho , YAMAJI Masayuki , SAKAI Hiroshi , YAMAMOTO Takashi , FUJII Masanori , HORIE Minoru

… Methods and Results: To compare biological variation in BNP and biological variation in factors of the renin-angiotensin-aldosterone system (RAS) in stable CHF patients with dilated cardiomyopathy (DCM), the BNP plasma levels and RAS factors were measured in 115 stable outpatients with DCM. …

Circulation Journal 75(8), 1897-1904, 2011-07-25

J-STAGE CrossRef References (35)
2

Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues

Demura Masashi , Wang Fen , Yoneda Takashi , Karashima Shigehiro , Mori Shunsuke , Oe Masashi , Kometani Mitsuhiro , Sawamura Toshitaka , Cheng Yuan , Maeda Yuji , Namiki Mikio , Ino Hidekazu , Fujino Noboru , Uchiyama Katsuharu , Tsubokawa Toshinari , Yamagishi Masakazu , Nakamura Yasuhiro , Ono Katsuhiko , Sasano Hironobu , Demura Yoshiki , Takeda Yoshiyu　　

… Nuclear receptor families NR4A [nerve growth factor-induced clone B (NGFIB), Nur-related factor 1 (NURR1) and neuron-derived orphan receptor 1 (NOR1)] and NR2F [chicken ovalbumin upstream promoter-transcription factor 1 (COUP-TFI), COUP-TFII and NR2F6) activate, whereas NR5A1 [steroidogenic factor 1 (SF1)] represses CYP11B2 (aldosterone synthase) gene transcription. …

Journal of Hypertension 29(6), 1185-1195, 2011-06

IR CrossRef
3

Prevention of Atherosclerosis in Overweight/Obese Patients : In Need of Novel Multi-Targeted Approaches

LIM Soo , DESPRES Jean-Pierre , KOH Kwang Kon

… At this stage, combined therapy of statins or PPAR agonists and renin-angiotensin-aldosterone system blockers to target multiple therapeutic pathways may optimally improve the cardiometabolic risk profile through both distinct and interrelated mechanisms. …

Circulation Journal 75(5), 1019-1027, 2011-04-25

J-STAGE Ichushi Web CrossRef References (91)
4

Pathogenesis and therapeutic implications of cardiorenal syndrome

NITTA Kosaku

Clinical and experimental nephrology 15(2), 187-194, 2011-04-01

References (69)
5

Aldosterone-induced kidney injury is mediated by NFκB activation

FUKUDA Seiichi , HORIMAI Chihiro , HARADA Kaori , WAKAMATSU Toshifumi , FUKASAWA Hiroshi , MUTO Susumu , ITAI Akiko , HAYASHI Matsuhiko

Clinical and experimental nephrology 15(1), 41-49, 2011-02-01

Ichushi Web References (27)
6

Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects

ITO Yuji , TAKEDA Ryoyu , KARASHIMA Shigehiro , YAMAMOTO Yasuhiro , YONEDA Takashi , TAKEDA Yoshiyu

Hypertens Res 34(1), 98-102, 2011-01-01

References (28) Cited by (1)
7

High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension

YAGI Shusuke , AKAIKE Masashi , AIHARA Ken-ichi , IWASE Takashi , YOSHIDA Sumiko , SUMITOMO UEDA Yuka , IKEDA Yasumasa , ISHIKAWA Kazue , MATSUMOTO Toshio , SATA Masataka

Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 34(1), 74-78, 2011-01-01

References (38)
8

Recent progress of diagnosis and treatment of primary aldosteronism [in Japanese]

大村昌夫 , 西川哲男

Japanese journal of clinical medicine 69(11), 2071-2076, 2011-11

Ichushi Web
9

Sympathetic nervous system and renin-angiotensin-aldosterone system in hypertension [in Japanese]

岩波純 , 茂木正樹 , 堀内正嗣

Japanese journal of clinical medicine 69(11), 1916-1919, 2011-11

Ichushi Web
10

Renin-angiotensin system blocker・selective aldosterone blocker [in Japanese]

栗栖智 , 木原康樹

Japanese journal of clinical medicine 69(-) (1006), 430-433, 2011-09

Ichushi Web
11

Drug discovery for improvement of chronic kidney disease and cardiovascular disease [in Japanese]

石澤啓介

Journal of the Pharmaceutical Society of Japan 131(9), 1347-1352, 2011
12

Novel therapeutic targets for heart failure [in Japanese]

朝倉正紀 , 北風政史

Cardioangiology 70(1), 113-116, 2011-07

Ichushi Web
13

Pharmacologic Therapy for Congestive Heart Failure: Renin-angiotensin-aldosterone Antagonist and β-Adrenergic Receptor Blockade [in Japanese]

吉川勉

The Journal of the Japan Medical Association 140(4), 745-749, 2011-07

Ichushi Web
14

Role of renin-angiotensin-aldosterone system (RAAS) in dysfunction of glucose and lipid metabolism: importance of angiotensin 2 blockade [in Japanese]

岩井將 , 堀内正嗣

Journal of the Japan Diabetes Society 54(3), 169-171, 2011-03

Ichushi Web
15

Chronic kidney disease and renin-angiotensin-aldosterone system [in Japanese]

林晃一

Cardioangiology 69(1), 68-74, 2011-01

Ichushi Web
16

直接的レニン阻害薬の臨床 (内分泌) -- (臨床分野での進歩) [in Japanese]

市原淳弘 , 伊藤裕

Annual review, 糖尿病・代謝・内分泌 2011, 216-223, 2011

Ichushi Web
17

原発性アルドステロン症の診断手引き (内分泌) -- (臨床分野での進歩) [in Japanese]

西川哲男 , 大村昌夫 , 齋藤淳

Annual review, 糖尿病・代謝・内分泌 2011, 208-215, 2011

Ichushi Web
18

Aldosterone antagonists and a direct renin inhibitor in the treatment of the metabolic syndrome [in Japanese]

田村尚久 , 中尾一和

Japanese journal of clinical medicine 69(-) (992), 592-596, 2011-01

Ichushi Web
19

A case of Hyperreninemic hypoaldosteronism with absorptive hypercalciuria, renal hypouricemia and high level of 1,25-dihydroxyvitamin D.

Saito Hiroshi , Mine Yusuke , Watanabe Hiroshi , Nagano Nobuhiko , Yoshida Ayako , Suzuki Junichi , Ishige Mika , Urakami Tatsuhiko , Takahashi Shori

　Hyperreninemic hypoaldosteronismは，アルドステロン合成障害により低ナトリウム血症，高カリウム血症，循環血漿量低下を来す疾患である。症例は体重増加不良を契機に発見され，低ナトリウム血症，高カリウム血症，高レニン血症から偽性低アルドステロン症の疑いで受診した。高レニン血症に比較して血中アルドステロン値は月齢基準範囲内を推移し，フルドロコルチゾンへの反応からHyperr …

Nihon Shoni Jinzobyo Gakkai Zasshi 24(1), 13-18, 2011

J-STAGE Ichushi Web CrossRef
20

Myocardial Protective Effect of Human Atrial Natriuretic Peptide in Cardiac Surgery : – "hANP Shot" in Clinical Safety Trial –

Sezai Akira , Wakui Shinji , Akiyama Kenji , Hata Mitsumasa , Yoshitake Isamu , Unosawa Satoshi , Shiono Motomi , Hirayama Atsushi

… The secondary endpoints were (1) the incidence of arrhythmia, and levels of (2) atrial and B-type natriuretic peptides, and cyclic guanosine monophosphate (cGMP), and (3) renin, angiotensin II, and aldosterone. …

Circulation Journal 75(9), 2144-2150, 2011

J-STAGE CrossRef Cited by (1)

Search Results:　 1-20 of 1947

Related Authors

Related Journals

Search Results: 1-20 of 1947

Related Authors

Related Journals

Search Results:　 1-20 of 1947